← Leaderboards
Jodi L. McBride
University Of Iowa
$4,533,005
Attributed
$4,533,005
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2007–20$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,533,005 · 7
By mechanism
R01$3,100,703 · 1
R00$729,861 · 1
R21$437,500 · 1
F32$95,066 · 1
K99$89,942 · 1
P51$79,933 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Beverly L Davidson$40,254,264
- Patrick L Sinn$13,054,693
- John F Engelhardt$56,184,900
- George J Weiner$29,916,936
- Robert Foster Mullins$9,156,220
Others in their field
Top investigators on “Huntington Disease”
- Jane S Paulsen · University Of Wisconsin-Madison$59,478,283
- Steven M Finkbeiner · J. David Gladstone Institutes$27,959,245
- Steven M Hersch · Emory University$23,594,084
- Lisa M. Ellerby · Buck Institute For Age Research$23,180,615
- Peggy C Nopoulos · University Of Iowa$21,784,331
- Christopher A Ross · Johns Hopkins University$20,194,349
Research focus
Huntington DiseaseCorpus Striatum StructureBehavioralNeurodegenerative DisordersGenesMotorGain Of FunctionCag RepeatMutantAffectBrainIn VivoMolecularMacaca MulattaCognitiveBrain RegionInjection Of Therapeutic AgentNeuropathologyGlutamineNonhuman PrimateAreaPathologyNerve DegenerationPutamen
Grant awards (14)
Cortico-basal ganglia connectivity in a non-human primate model of Huntington's disease$530,054
R01 · FY2020 · NS · contact PI
Cortico-basal ganglia connectivity in a non-human primate model of Huntington's disease$581,459
R01 · FY2019 · NS · contact PI
Cortico-basal ganglia connectivity in a non-human primate model of Huntington's disease$631,913
R01 · FY2018 · NS · contact PI
Cortico-basal ganglia connectivity in a non-human primate model of Huntington's disease$644,404
R01 · FY2017 · NS · contact PI
Cortico-basal ganglia connectivity in a non-human primate model of Huntington's disease$712,873
R01 · FY2016 · NS · contact PI
Global RNA Interference Therapy for Huntingtons Disease$437,500
R21 · FY2016 · NS · contact PI
RNAi therapy for Huntingtons disease: safety & efficacy in the nonhuman primate$234,718
R00 · FY2013 · NS · contact PI
RNAi therapy for Huntingtons disease: safety & efficacy in the nonhuman primate$246,143
R00 · FY2012 · NS · contact PI
RNAi therapy for Huntingtons disease: safety & efficacy in the nonhuman primate$249,000
R00 · FY2011 · NS · contact PI
RNAI THERAPY FOR HUNTINGTONS DISEASE: SAFEY & EFFICACY IN THE NONHUMAN PRIMATE$43,647
P51 · FY2011 · RR · contact PI
SYSTEMIC DELIVERY RNA INTERFERENCE USING AAV9; TREAT HUNTINGTON'S DISEASE$36,286
P51 · FY2011 · RR · contact PI
RNAi therapy for Huntingtons disease: safety & efficacy in the nonhuman primate$89,942
K99 · FY2010 · NS · contact PI
Non-alledle specific RNAi as a potential therapy for Huntington's disease$49,646
F32 · FY2008 · NS · contact PI
Non-alledle specific RNAi as a potential therapy for Huntington's disease$45,420
F32 · FY2007 · NS · contact PI